American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...

Best AI crypto token to explore in 2025! Discover why Dawgz AI is top AI-powered cryptocurrency and how other cutting-edge ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...

The continued solid uptake of BD's products is expected to have driven fiscal first-quarter revenues despite transitory ...

EST Becton Dickinson (BDX) to separate biosciences, diagnostic solutions businessMaximize Your Portfolio with Data Driven ...

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences ...

Biosciences and Diagnostic Solutions is expected to have approximately ... up from $14.25-$14.60 compared to the consensus of $14.40. Price Action: BDX stock is down 3.88% at $235.56 at the ...

The plan is to position the New BD as a differentiated MedTech leader and enable optimized investment to accelerate the innovation pipeline and ongoing margin enhancement through BD Excellence to ...